Clinical Trial Update: Impact of Intraventricular Electrical Activation in Resynchronization Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intraventricular electrical activation in resynchronization therapy for heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Dilated Cardiomyopathy
• Heart Failure

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Heart Failure, Cardiomyopathy, Dilated | Phase 2 | Status: COMPLETED